Reference Montelukast

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Asthma and RhinitisRespiratory Disorders

Phase 1

Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

CompletedNCT02322671

GlaxoSmithKlineRespiratory Disorders

Start: 2015-02-23End: 2015-04-20Updated: 2017-05-15

Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions

CompletedNCT02658422

GlaxoSmithKlineAsthma and Rhinitis, Respiratory Disorders

Start: 2015-08-18End: 2015-09-21Updated: 2017-05-09